Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combining Antidepressants to Hasten Remission From Depression
NCT00519428Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Aug 2007
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of escitalopram, bupropion in major depressive disorder (MDD), sponsored by New York State Psychiatric Institute. Started Aug 2007; status: completed.
02
Drugs
escitaloprambupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00519428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519428.